NCT00240253 · Interventional trial
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
Overall registry status Completed
Phase 4
Conditions Type 2 Diabetes Mellitus
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory